We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01065701
Recruitment Status : Completed
First Posted : February 9, 2010
Last Update Posted : October 26, 2017
Information provided by (Responsible Party):

February 7, 2010
February 9, 2010
October 26, 2017
July 2009
August 2010   (Final data collection date for primary outcome measure)
proportion of children attained satisfactory sedation [ Time Frame: one hour ]
Same as current
Complete list of historical versions of study NCT01065701 on ClinicalTrials.gov Archive Site
time to onset of sedation [ Time Frame: one hour ]
Same as current
Not Provided
Not Provided
Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children
Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children - a Double-blinded Randomized Controlled Trial
Intranasal dexmedetomidine has shown to be an effective sedative when used prior to anaesthetic induction as premedication. 1mcg/kg intranasal dexmedetomidine was used in previous study and it produced satisfactory sedation in more than 50% of the children at the time of anaesthetic induction with no adverse effect. In this study we aim to compare 1mcg/kg with 2mcg/kg intranasal dexmedetomidine in children. We expect more children would attain satisfactory sedation prior to anaesthetic induction when higher dose is used.
Not Provided
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Patient Between 1-8 Years Old Undergoing Elective Surgery at Queen Mary Hospital
Drug: Dexmedetomidine
Intranasal dexmedetomidine is given as premedication prior to induction of anesthesia
  • Active Comparator: 1mcg/kg
    1mcg/kg intranasal dexmedetomidine administered 45 minutes befoe anesthesia induction
    Intervention: Drug: Dexmedetomidine
  • Active Comparator: 2mcg/kg
    2mcg/kg intranasal dexmedetomidine given 45 minutes prior to anesthetic induction
    Intervention: Drug: Dexmedetomidine
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
August 2010
August 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 1-12 years old
  • American Society of Anesthesiologists (ASA) 1-2
  • Elective surgery
  • Children with autism or pervasive personality disorder

Exclusion Criteria:

  • American Society of Anaesthesiologists (ASA) 3-5
  • Allergy or hypersensitive reaction to dexmedetomidine
  • Known cardiac arrhythmia or congenital heart disease
  • Mentally disabled
Sexes Eligible for Study: All
1 Year to 8 Years   (Child)
Contact information is only displayed when the study is recruiting subjects
Hong Kong
Not Provided
Not Provided
YUEN, Vivian Man-ying, The University of Hong Kong
The University of Hong Kong
Not Provided
Principal Investigator: Vivian M Yuen, MBBS Associate Consultant, Queen Mary Hospital
The University of Hong Kong
October 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP